High-dose chemotherapy, autologous stem cell transplantation failed to improve ... HemOncToday Patients received rituximab (Rituxan; Genentech, Idec Pharmaceuticals) in both arms during induction treatment in two of the trials. Median follow-up was up to 5 years in two trials and roughly 9 years for the other two trials. ... |
